Synthesis 2017; 49(09): 2057-2062
DOI: 10.1055/s-0036-1588133
paper
© Georg Thieme Verlag Stuttgart · New York

A Borrowing Hydrogen Approach to the Synthesis of RS-67,333

Elodie Carbonnel
VFP Therapies, R & D Laboratory, IRCOF, Rue Tesnière, 76131 Mont Saint Aignan, France   Email: vgembus@vfp-therapies.com
,
Florent Alix
VFP Therapies, R & D Laboratory, IRCOF, Rue Tesnière, 76131 Mont Saint Aignan, France   Email: vgembus@vfp-therapies.com
,
Vincent Gembus*
VFP Therapies, R & D Laboratory, IRCOF, Rue Tesnière, 76131 Mont Saint Aignan, France   Email: vgembus@vfp-therapies.com
› Author Affiliations
Further Information

Publication History

Received: 07 November 2016

Accepted after revision: 14 December 2016

Publication Date:
10 January 2017 (online)


Abstract

A new strategy using the borrowing hydrogen methodology to access the 5-HT4R agonist RS-67,333 is presented. Especially, this selective and highly potent ligand of 5-HT4 receptor was obtained quickly and efficiently by catalytic alkylation of a ketone with various alcohols in the presence of a catalytic amount of (Cp*IrCl2)2.

Supporting Information

 
  • References

    • 1a Meltzer CC, Smith G, DeKosky ST, Pollock BG, Mathis CA, Moore RY, Kupfer DJ, Reynolds CF. Neuropsychopharmacology 1998; 18: 407
    • 1b Reynolds GP, Mason SL, Meldrum A, De Keczer S, Parnes H, Eglen RM, Wong EH. F. Br. J. Pharmacol. 1995; 114: 993
    • 1c Bockaert J, Ansanay H, Waeber C, Sebben M, Fagni L, Dumuis A. CNS Drugs 1994; 1: 6

      Selected references:
    • 2a Darcet F, Gardier AM, David DJ, Guilloux J.-P. Neurosci. Lett. 2016; 616: 197
    • 2b Claeysen S, Bockaert J, Giannoni P. ACS Chem. Neurosci. 2015; 6: 940
    • 2c Quiedeville A, Boulouard M, Hamidouche K, Da Silva Costa-Aze V, Nee G, Rochais C, Dallemagne P, Fabis F, Freret T, Bouet V. Behav. Brain Res. 2015; 293: 10
    • 2d Giannoni P, Gaven F, de Bundel D, Baranger K, Marchetti-Gauthier E, Roman FS, Valjent E, Marin P, Bockaert J, Rivera S, Claeysen S. Front. Aging Neurosci. 2013; 5: 96
    • 2e Freret T, Bouet V, Quiedeville A, Nee G, Dallemagne P, Rochais C, Boulouard M. Behav. Brain Res. 2012; 230: 304
    • 2f Marchetti E, Chaillan FA, Dumuis A, Bockaert J, Soumireu-Bourat B, Roman FS. Neuropharmacology 2004; 47: 1021
    • 2g Lelong V, Lhonneur L, Dauphin F, Boulouard M. Naunyn-Schmiedebergs Arch. Pharmacol. 2003; 367: 621
    • 2h Lamirault L, Guillou C, Thal C, Simon H. Prog. Neuropsychopharmacol. Biol. Psychiatry 2003; 27: 185
    • 2i Moser PC, Bergis OE, Jegham S, Lochead A, Duconseille E, Terranova JP, Caille D, Bergue-Bestel I, Lezoualc’h F, Fischmeister R, Dumuis A, Bockaert J, George P, Soubrié P, Scatton B. J. Pharmacol. Exp. Ther. 2002; 302: 731
    • 2j Robert SJ, Zugaza JL, Fischmeister R, Gardier AM. J. Biol. Chem. 2001; 276: 44881
    • 2k Marchetti E, Dumuis A, Bockaert J, Soumireu-Mourat B, Roman FS. Neuropharmacology 2000; 39: 2017
    • 2l Galeotti N, Ghelardini C, Bartolini A. J. Pharmacol. Exp. Ther. 1998; 286: 1115
    • 2m Consolo S, Arnaboldi S, Giorgi S, Russi G, Ladinsky H. Neuroreport 1994; 5: 1230
  • 3 Eglen RM, Bonhaus DW, Johnson LG, Leung E, Clark RD. Br. J. Pharmacol. 1995; 115: 1387
  • 4 Lecoutey C, Hedou D, Freret T, Giannoni P, Gaven F, Since M, Bouet V, Ballandonne C, Corvaisier S, Malzert-Fréon A, Mignani S, Cresteil T, Boulouard M, Claeysen S, Rochais C, Dallemagne P. Proc. Natl. Acad. Sci. U.S.A. 2014; 111: E3825
  • 5 Lucas G, Rymar VV, Du J, Mnie-Filali O, Bisgaard C, Manta S, Lambas-Senas L, Wiborg O, Haddjeri N, Pineyro G, Sadikot AF, Debonnel G. Neuron 2007; 55: 712
  • 6 Clark RD, Jahangir A, Langston JA, Weinhardt KK, Miller AB, Miller AB, Leung E, Eglen RM. Bioorg. Med. Chem. Lett. 1994; 4: 2477
  • 7 Clark RD, Eglen R, Jahangir A, Miller AB, Gardner JO. Patent PCT Int. Appl. WO 1994027965 A1, 1994
  • 8 Rochais C, Lecoutey C, Gaven F, Giannoni P, Hamidouche K, Hedou D, Dubost E, Genest D, Yahiaoui S, Freret T, Bouet V, Dauphin F, Sopkova de Oliveira Santos J, Ballandonne C, Corvaisier S, Malzert-Fréon A, Legay R, Boulouard M, Claeysen S, Dallemagne P. J. Med. Chem. 2015; 58: 3172

    • Selected reviews:
    • 9a Yang Q, Wang Q, Yu Z. Chem. Soc. Rev. 2015; 44: 2305
    • 9b Obora Y. ACS Catal. 2014; 4: 3972
    • 9c Gunanathan C, Milstein D. Science 2013; 341: 249
    • 9d Dobereiner GE, Crabtree RH. Chem. Rev. 2010; 110: 681
    • 9e Pan S, Shibata T. ACS Catal. 2013; 3: 704
    • 9f Guillena G, Ramón DJ, Yus M. Angew. Chem. Int. Ed. 2007; 46: 2358
    • 9g Hamid MH. S. A, Slatford PA, Williams JM. J. Adv. Synth. Catal. 2007; 349: 1555
    • 9h Fujita KI, Yamaguchi R. Synlett 2005; 560

      Selected references:
    • 10a Huang F, Liu Z, Yu Z. Angew. Chem. Int. Ed. 2016; 55: 862
    • 10b Elangovan S, Sortais J.-P, Beller M, Darcel C. Angew. Chem. Int. Ed. 2015; 54: 14483
    • 10c Li F, Ma J, Wang J. J. Org. Chem. 2014; 79: 10447
    • 10d Martínez R, Ramón DJ, Yus M. Tetrahedron 2006; 62: 8988
    • 10e Kwon MS, Kim N, Seo SH, Park IS, Cheedrala RK, Park J. Angew. Chem. Int. Ed. 2005; 44: 6913
    • 10f Fujita K.-I, Asai C, Yamaguchi T, Hanasaka F, Yamaguchi R. Org. Lett. 2005; 7: 4017
    • 10g Taguchi K, Nakagawa H, Hirabayashi T, Sakaguchi S, Ishii Y. J. Am. Chem. Soc. 2004; 126: 72